[RGLS] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
02-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 0.55%
YoY- -0.26%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 18 18 18 483 3,834 736 4,759 -60.51%
PBT -5,015 -13,847 -21,736 -21,098 -21,037 -11,973 -7,338 -6.14%
Tax 1 118 -128 -8 -2 10 10 -31.85%
NP -5,016 -13,847 -21,608 -21,090 -21,035 -11,973 -7,348 -6.16%
Tax Rate - - - - - - - -
Total Cost 5,034 13,865 21,626 21,573 24,869 12,709 12,107 -13.60%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -27,866.67 -76,927.78 -120,044.44 -4,366.46 -548.64 -1,626.77 -154.40 137.63%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -3.00 -15.93 -48.76 -47.95 -49.42 -33.13 -24.50 -29.52%
EPS Diluted -3.00 -15.93 -48.76 -47.95 -49.42 -32.07 -24.50 -29.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.